Feb 28, 2025
In part two of this two-part series, Dr. Vikram Karnik and Dr. Lorraine Kalia discuss the preclinical data and epidemiological data that led us to the phase three study on exenatide.
Show reference:
Feb 27, 2025
In part one of this two-part series, Dr. Vikram Karnik and Dr. Lorraine Kalia discuss recent clinical trials on exenatide as a disease-modifying therapy for Parkinson disease.
Show reference:
Feb 26, 2025
Dr. BJ Hicks and Dr. Aaron Shoskes discuss the rising incidence of ischemic stroke in young adults.
Show references:
https://www.neurology.org/doi/10.1212/WNL.0000000000213447
Feb 25, 2025
Dr. Tesha Monteith discusses Journavx (suzetrigine), a new medication for pain management.
Show references:
https://link.springer.com/article/10.1007/s40122-024-00697-0
Feb 24, 2025
Dr. Stacey Clardy breaks down the understanding of antiphospholipid syndrome.
Show references:
https://ard.eular.org/article/S0003-4967(24)10290-7/fulltext